Big heart, no longer a big problem: using catecholamine-based quantifications may be an effective means to prescribe exercise to non-obstructive hypertrophic cardiomyopathy patients
- PMID: 30891752
- PMCID: PMC6488011
- DOI: 10.1113/JP277970
Big heart, no longer a big problem: using catecholamine-based quantifications may be an effective means to prescribe exercise to non-obstructive hypertrophic cardiomyopathy patients
Keywords: Cardiovascular Physiology; Catecholamines; Exercise Physiology.
Comment on
-
Catecholamine response to exercise in patients with non-obstructive hypertrophic cardiomyopathy.J Physiol. 2019 Mar;597(5):1337-1346. doi: 10.1113/JP277494. Epub 2019 Jan 9. J Physiol. 2019. PMID: 30552684 Free PMC article.
Similar articles
-
[The relations between atrial natriuretic factor release and adrenergic activation in hypertrophic cardiomyopathy].Recenti Prog Med. 1993 Jul-Aug;84(7-8):495-502. Recenti Prog Med. 1993. PMID: 8356302 Italian.
-
Impaired response of left ventricular relaxation to exercise-induced adrenergic stimulation in patients with hypertrophic cardiomyopathy.J Am Coll Cardiol. 1996 Dec;28(7):1738-45. doi: 10.1016/S0735-1097(96)00378-6. J Am Coll Cardiol. 1996. PMID: 8962560
-
Exercising caution: is there a role for exercise testing in the hypertrophic cardiomyopathy population?J Physiol. 2019 Apr;597(7):1789-1790. doi: 10.1113/JP277778. Epub 2019 Mar 10. J Physiol. 2019. PMID: 30807651 Free PMC article. No abstract available.
-
Pathogenesis of hypertrophic cardiomyopathy: another viewpoint.Int J Cardiol. 1991 Jan;30(1):9-13. doi: 10.1016/0167-5273(91)90118-9. Int J Cardiol. 1991. PMID: 1991674 Review.
-
Exercise in patients with hypertrophic cardiomyopathy: A review of current evidence, national guideline recommendations and a proposal for a new direction to fitness.J Sci Med Sport. 2017 Apr;20(4):333-338. doi: 10.1016/j.jsams.2016.09.007. Epub 2016 Sep 20. J Sci Med Sport. 2017. PMID: 27707537 Review.
References
-
- Billman GE (2002). Aerobic exercise conditioning: a nonpharmacological antiarrhythmic intervention. J Appl Physiol (1985) 92, 446–454. - PubMed
-
- Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE & Yancy CW (2011). 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary. Circulation 124, 2761–2796. - PubMed
-
- Maron BJ, Chaitman BR, Ackerman MJ, Bayés de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, Estes NA 3rd, Araújo CG, Liang DH, Mitten MJ, Myerburg RJ, Pelliccia A, Thompson PD, Towbin JA & Van Camp SP (2004). Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 109, 2807–2816. - PubMed
-
- Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NAM 3rd, Cooper LT Jr, Link MS & Maron MS (2015). Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 66, 2362–2371. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources